Celldex Therapeutics Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
CLDX$31.24+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of December 31, 2024, our significant leased properties are described below.
| · · · · · · | |||
|---|---|---|---|
| | Approximate | | |
| Property Location | Square Feet | Use | Lease Expiration Date |
| Hampton, New Jersey | 33,400 | Headquarters, Office and Laboratory | July 2027(1) |
| Fall River, Massachusetts | 36,300 | Manufacturing, Office and Laboratory | July 2027(2) |
| New Haven, Connecticut | 17,700 | Office and Laboratory | October 2026 |
| (1) | Lease includes two renewal options of two years. |
| (2) | Lease includes one renewal option of three years. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.